Cargando…
SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells
The COVID-19 pandemic caused by SARS-CoV-2 has lasted for more than two years. Despite the presence of very effective vaccines, the number of virus variants that escape neutralizing antibodies is growing. Thus, there is still a need for effective antiviral treatments that target virus replication in...
Autores principales: | Yu, Yu-Qiang, Herrmann, Alexandra, Thonn, Veronika, Cordsmeier, Arne, Neurath, Markus F., Ensser, Armin, Becker, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033063/ https://www.ncbi.nlm.nih.gov/pubmed/35455942 http://dx.doi.org/10.3390/cells11081262 |
Ejemplares similares
-
Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System
por: Cordsmeier, Arne, et al.
Publicado: (2023) -
SMYD2 targets RIPK1 and restricts TNF-induced apoptosis and necroptosis to support colon tumor growth
por: Yu, Yu-qiang, et al.
Publicado: (2022) -
Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination
por: Herrmann, Alexandra, et al.
Publicado: (2021) -
Re-Analysis of the Widely Used Recombinant Murine Cytomegalovirus MCMV-m157luc Derived from the Bacmid pSM3fr Confirms Its Hybrid Nature
por: Cordsmeier, Arne, et al.
Publicado: (2023) -
A Genetically Encoded Dark-to-Bright Biosensor for Visualisation of Granzyme-Mediated Cytotoxicity
por: Bednar, Christopher, et al.
Publicado: (2023)